Stock Earnings Enanta Pharmaceuticals Inc (ENTA) receives an Underweight rating from JP Morgan Enanta Pharmaceuticals Inc’s recent filing unveils that its President and CEO Luly Jay R. acquired Company’s shares for reported $0.26
Stock Earnings ENTA’s short interest falls to 2.5 million shares The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or